How Often Should You Get IV Drips? A Doctor-Led Framework | ALIV

Medically Reviewed by Dr. Sunita Tandulwadkar | Written by ALIV

One of the most common questions at ALIV's Pune and Mumbai clinics after a patient's first session: "How often should I come back?" And one of the most honest answers in IV therapy: there is no universal correct answer. The right frequency depends on your goal, your baseline blood markers, your specific deficiency or condition, and how your body responds to the initial sessions. What follows is the clinical framework we use to think about it.

Phase 1: The Loading Phase — Correcting the Deficit

For patients starting IV therapy to correct a specific deficiency or to provide intensive support for a chronic condition, the initial phase involves more frequent sessions. This is the loading phase — its purpose is to raise depleted levels to a clinical baseline quickly and efficiently.

A typical loading schedule at ALIV is two to three sessions per week for two to three weeks, or one session per week for four to six weeks, depending on the severity of the deficiency and the patient's schedule. This approach mirrors clinical loading protocols used in hospital medicine — B12 deficiency treatment, for example, uses daily IM injections for a week in severe cases before shifting to weekly and then monthly maintenance.

The loading phase is not indefinite. It has a clear clinical endpoint: blood markers reaching target ranges or symptoms resolving to an acceptable level. ALIV reassesses at the end of every loading course rather than automatically rolling patients into continued intensive sessions.

Phase 2: The Consolidation Phase

After the loading phase, most patients shift to weekly sessions for three to four weeks. The goal here is maintaining the therapeutic levels achieved during loading while reducing the frequency progressively. This is also when it becomes clearer how well the patient's body is sustaining levels between sessions — an important indicator for designing the maintenance phase that follows.

Phase 3: Maintenance — Long-Term Sustainability

Long-term maintenance frequency varies considerably by individual and clinical context. The most common patterns at ALIV:

Monthly sessions are appropriate for most patients in general wellness and longevity maintenance — supporting optimal micronutrient levels, periodic NAD+ top-ups, or seasonal immune support. For many patients with healthy gut absorption who also take appropriate oral supplements between sessions, monthly IV maintenance sustains the levels achieved during the loading course effectively.

Every two to three weeks is appropriate for patients managing chronic conditions — fibromyalgia, PCOS, post-viral fatigue — where IV support is an active component of the clinical management plan and where oral supplementation alone is insufficient to sustain levels.

Every three to four months (seasonal) for robust, healthy patients seeking periodic optimisation alongside consistent oral supplementation — particularly for NAD+ maintenance when oral NMN is taken daily between sessions.

Goal-Specific Guidance

• General wellness and prevention: Monthly maintenance after an initial loading course of four to six sessions.
• Confirmed deficiency (B12, ferritin, magnesium): Loading course first (two to three sessions per week for two to three weeks), then monthly maintenance with blood monitoring every three months.
• Skin and glutathione protocols: Weekly or bi-weekly sessions for eight to twelve sessions, then monthly maintenance — skin changes require sustained antioxidant levels to produce visible results.
• Athletic recovery: Tied to training cycle rather than a fixed calendar — before or after intensive training blocks rather than on a fixed weekly schedule.
• NAD+ for longevity: An initial course of four to six sessions, then monthly or bi-monthly maintenance alongside daily oral NMN. Read more about the NAD+ IV programme at ALIV.

When More Is Not Better

This is important enough to state directly: IV therapy is not a case where higher frequency produces proportionally better results. Fat-soluble vitamins can accumulate to toxic levels with excessive dosing. Repeated high-dose iron administration is associated with oxidative stress. Even water-soluble vitamins at very high cumulative doses carry risks at the extremes. Any clinic that encourages unlimited frequent sessions without blood monitoring is not acting in your clinical interest — it is maximising revenue at the expense of appropriate clinical management.

At ALIV, blood markers are reassessed at the end of every loading course and every three to six months for patients on ongoing maintenance programmes. Frequency is adjusted based on what the blood work shows — not based on a fixed subscription model.

Frequently Asked Questions

Is monthly IV therapy safe long-term?

For most patients receiving appropriately dosed standard formulations with periodic blood monitoring, monthly sessions have a good long-term safety profile. The critical requirement is reassessment every three to six months to confirm that levels are remaining in appropriate ranges and that no imbalance is developing. ALIV builds this monitoring into every ongoing programme.

Can I do IV therapy every week indefinitely?

Weekly sessions are appropriate during loading and consolidation phases and for certain active treatment protocols. Indefinitely weekly IV therapy without clinical monitoring and periodic reassessment is not advisable. The frequency should be reviewed at each phase of treatment and reduced to the minimum required to maintain clinical benefit.

What happens if I stop IV therapy?

Your levels will gradually return toward pre-treatment baseline — the rate depending on your dietary intake, gut absorption, and ongoing nutritional demand. For patients with persistent absorption issues, stopping IV therapy without adequate oral maintenance supplementation may lead to returning deficiency symptoms over weeks to months. Your ALIV doctor will build a transition plan when the time is appropriate.

How do I know when to move from loading to maintenance?

The transition point is clinical, not arbitrary. Blood markers reaching target ranges, symptoms resolving to an acceptable level, and the response to sessions plateauing (each additional session adding progressively less incremental benefit) are the signals. Your ALIV doctor will review these together with you at the end of your initial course.

Is there any benefit to doing more sessions than recommended?

Beyond the optimal clinical frequency for your specific markers and goals, additional sessions do not produce additional clinical benefit — and at high frequencies, carry accumulation risks for certain nutrients. The goal of IV therapy at ALIV is to do as much as is clinically needed and no more than that.

Unsure how often you should be coming to ALIV?

Our clinical team in Pune and Mumbai builds an individualised session schedule based on your specific blood markers, health goals, and treatment response — not a standard package. Visit alivtherapy.in to book your assessment.

Medically Reviewed by Dr. Sunita Tandulwadkar. This article is for informational purposes only and does not constitute medical advice. Therapies offered by ALIV are proprietary, experimental protocols and results vary by individual.